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Background: Stroke severity is an important outcome predictor for intracerebral hemorrhage (ICH) but is
typically unavailable in administrative claims data. We validated a claims-based stroke severity index
(SSI) in patients with ICH in Taiwan.
Methods: Consecutive ICH patients from hospital-based stroke registries were linked with a nationwide
claims database. Stroke severity, assessed using the National Institutes of Health Stroke Scale (NIHSS),
and functional outcomes, assessed using the modiﬁed Rankin Scale (mRS), were obtained from the
registries. The SSI was calculated based on billing codes in each patient's claims. We assessed two types
of criterion-related validity (concurrent validity and predictive validity) by correlating the SSI with the
NIHSS and the mRS. Logistic regression models with or without stroke severity as a continuous covariate
were ﬁtted to predict mortality at 3, 6, and 12 months.
Results: The concurrent validity of the SSI was established by its signiﬁcant correlation with the
admission NIHSS (r ¼ 0.731; 95% conﬁdence interval [CI], 0.705e0.755), and the predictive validity was
veriﬁed by its signiﬁcant correlations with the 3-month (r ¼ 0.696; 95% CI, 0.665e0.724), 6-month
(r ¼ 0.685; 95% CI, 0.653e0.715) and 1-year (r ¼ 0.664; 95% CI, 0.622e0.702) mRS. Mortality models
with NIHSS had the highest area under the receiver operating characteristic curve, followed by models
with SSI and models without any marker of stroke severity.
Conclusions: The SSI appears to be a valid proxy for the NIHSS and an effective adjustment for stroke
severity in studies of ICH outcome with administrative claims data.
© 2016 The Authors. Publishing services by Elsevier B.V. on behalf of The Japan Epidemiological
Association. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Intracerebral hemorrhage (ICH) remains a major challenge for
public health. According to a large meta-analysis from 36 studies
conducted worldwide between 1980 and 2008, the overall, Tainan Sin Lau Hospital, 57,
2, Taiwan.
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d/4.0/).incidence of ICH is 24.6 per 100,000 person-years, with a median
30-day mortality of 40.4%, and only 12%e39% of patients are able to
remain independent after ICH.1 Despite the decrease in annual
incidence of ICH from 2000 to 2010, the short- and long-term
mortality following ICH did not change.2 Stroke severity, assessed
using a standardized stroke scale like the National Institutes of
Health Stroke Scale (NIHSS), is an important outcome predictor for
ICH.3,4 Every one-point increase in the NIHSS leads to a 10% higher
risk of poor 1-year functional outcome.4
Administrative claims data, which are derived from claims for
routine clinical practices, often include demographic information,n Epidemiological Association. This is an open access article under the CC BY-NC-ND
Table 1
Multiple linear regression model for the stroke severity index.
Predictor Coefﬁcient
Airway suctioning 3.5083
Bacterial sensitivity test 1.3642
General ward stay 5.5761
ICU stay 4.1770
Nasogastric intubation 4.5809
Osmotherapy (mannitol or glycerol) 2.1448
Urinary catheterization 1.6569
Constant 9.6804
ICU, intensive care unit.
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cations. They contain much clinical information and may be an
efﬁcient and affordable resource for ICH research. However, before
conducting clinical studies using these data, it is essential to
determine whether the available claims data could sufﬁciently
reﬂect the clinical manifestations of a health condition. For
example, several studies have focused on developing algorithms to
identify subtypes of stroke using administrative claims data.5 For
the identiﬁcation of presence of ICH, the algorithms in previous
studies generally showed high positive predictive values, ranging
from 79% to 97%.5 Researchers are increasingly using administrative
claims data to investigate risk factors,6,7 epidemiologic trends,8,9
and outcomes of ICH.10e12 Nevertheless, administrative claims
data usually do not contain information on stroke severity.13,14
Therefore, stroke outcome studies based on administrative claims
data alone may have inadequate adjustment for stroke severity.15
Recently, we developed a claims-based stroke severity index
(SSI), which has been validated as an effective proxy for stroke
severity in patients with acute ischemic stroke (AIS).16 The SSI is
signiﬁcantly correlated with patient admission NIHSS scores.
However, the validity of the SSI for ICH patients has not been
determined. In this study, we validated the SSI in patients with ICH
from three hospitals in Taiwan.
2. Methods
Overall, we linked stroke registry data with the National Health
Insurance Research Database (NHIRD) using non-unique charac-
teristics of a patient with ICH, as described previously.16e18We then
computed SSI based on claims data of the NHIRD and evaluated the
criterion-related validity of the SSI. Finally, we examined the
change in model performance resulting from adding the SSI to
models for predicting mortality after ICH.
2.1. Stroke registry data
We identiﬁed adult patients with an ICH diagnosis in stroke
registries from the Chi Mei Medical Center, the Landseed Hospital,
and the Ditmanson Medical Foundation Chiayi Christian Hospital.
Patients with in-hospital stroke were excluded. The study hospitals
registered all stroke patients admitted within 10 days of symptom
onset following a protocol that has been reported elsewhere.19 ICH
was deﬁned as “a non-traumatic abrupt onset of symptoms with
relevant focal neurological deﬁcit, with or without headache or
altered level of consciousness, with a focal collection of blood
within the brain parenchyma on computed tomography or mag-
netic resonance imaging that was not a hemorrhagic conversion of
a cerebral infarction”.19 Stroke severity was determined using the
NIHSS. The functional status of patients (who had provided prior
written informed consent for follow-up) was evaluated using the
mRS at 3 months, 6 months, and 1 year after ICH by in-person
assessment or by telephone interview. To ensure patient anonym-
ity, we retrieved only the gender, birth date, admission date,
discharge date, NIHSS score at admission, andmRS scores at follow-
up from the registry databases. The study protocol was approved
independently by the Institutional Review Boards of the three
participating hospitals.
2.2. National Health Insurance Research Database linkage
The National Health Insurance (NHI) program is a compulsory,
single-payer healthcare program that covers virtually the entire
population of Taiwan. The program provides universal coverage for
prescription medications, inpatient care, and ambulatory care. The
National Health Insurance Research Database (NHIRD), whichconsists of all administrative claims data on NHI enrollees, is
maintained and released for research by the National Health
Research Institutes of Taiwan. Traceable personal identiﬁers in the
NHIRD were scrambled to protect patient privacy and
conﬁdentiality.20
To identify the inpatient population of ICH patients in the
NHIRD, we extracted the data of all patients hospitalized between
2006 and 2010 for ICH (International Classiﬁcation of Diseases,
Ninth Revision, Clinical Modiﬁcation [ICD-9-CM] diagnosis code
431) as their principal or secondary discharge diagnosis from a
stroke-speciﬁc NHIRD data set. Four non-unique patient charac-
teristics (gender, birth date, admission date, and discharge date)
were used to link registry data with the NHIRD.16e18 If more than
one patient in either the stroke registries or the NHIRD shared the
same values in all four matching characteristics, they were
excluded. Errors in coding or entering data in administrative claims
data might also be present, which could cause the failure of link-
age.21 Successfully linked cases comprised the study cohort, and the
linked hospitalization record in the NHIRDwas deﬁned as the index
hospitalization.2.3. Measurements
For each case in the study cohort, we extracted all the diagnosis
codes from the index hospitalization, as well as inpatient and
outpatient claims within the 1-year look-back period before the
index hospitalization.10,22 Patients were identiﬁed as having a co-
morbidity if its corresponding ICD-9-CM codes (eTable 1) appeared
in at least one inpatient claim or three outpatient claims during the
1-year look-back period.10,22 Severity of comorbidities was then
summarized using a modiﬁed version of the Charlson comorbidity
index (CCI),23 which excluded cerebrovascular disease and hemi-
plegia. The modiﬁed CCI has been validated as a measure of co-
morbidity for predicting mortality and functional outcome in ICH
patients24 and was dichotomized into low comorbidity (<2) or high
comorbidity (2) for analyses.24
Previously, the SSI was developed to predict patient NIHSS score
at admission and was validated for AIS patients by linking registry
data with the NHIRD.16 The SSI contains seven predictors: airway
suctioning, bacterial sensitivity test, general ward stay, ICU stay,
nasogastric intubation, osmotherapy, and urinary catheterization
(Table 1). Among all the AIS patients, the SSI was highly correlated
with the admission NIHSS score.16 The presence or absence of each
predictor was determined using detailed billing codes (eTable 2) in
claims data and was subsequently entered in a multiple linear
regression equation (Table 1) to calculate the SSI for each patient.
The outcomes of interest, including patient NIHSS score at
admission; functional outcomes assessed using the mRS at 3
months, 6 months, and 1 year after the index ICH; and mortality
status were obtained from the registry databases.
Table 2
Study patient characteristics.
Characteristic n ¼ 1360
Mean (SD) age, years 61.0 (14.6)
Female sex 487 (35.8)
Modiﬁed CCI
0 or 1 1053 (77.4)
2 307 (22.6)
Hypertension 1014 (74.6)
Diabetes mellitus 337 (24.8)
Hyperlipidemia 208 (15.3)
Prior stroke 231 (17.0)
Atrial ﬁbrillation 19 (1.4)
Coronary heart disease 42 (3.1)
Chronic kidney disease 87 (6.4)
Mean (SD) NIHSS score 17.0 (12.9)
Mean (SD) SSI score 14.9 (6.8)
CCI, Charlson comorbidity index; NIHSS, National Institutes of
Health Stroke Scale.
SD, standard deviation; SSI, stroke severity index.
Data are presented as numbers (percentage) unless otherwise
speciﬁed.
Fig. 1. Performance of mortality models for intracerebral hemorrhage. NIHSS, National
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Statistical analyses were performed using Stata 13.1 (StataCorp,
College Station, TX, USA). We summarized continuous variables
using means and standard deviations and categorical variables
using counts and percentages. A two-tailed P value of <0.05 was
considered statistically signiﬁcant. Criterion-related validity is the
extent to which the score from a new measure correlates with that
of other measures evaluating the same or a very similar construct.25
In order to establish the SSI as a valid proxy measure for stroke
severity, we evaluated two types of criterion-related validity:
concurrent validity (the extent to which the SSI correlates with the
NIHSS) and predictive validity (the extent to which the SSI predicts
future functional outcomes). Concurrent validity was tested using
the Pearson correlation coefﬁcient between the SSI and the
admission NIHSS.26 Predictive validity was assessed using the cor-
relations between the SSI and the mRS at 3 months, 6 months, and
1 year.26
To investigate whether including the measure of stroke severity
intomortalitymodels enhances the predictive ability of themodels,
we ﬁrst ﬁtted base logistic regression models to predict 3-month,
6-month, and 1-year mortality using age, sex, modiﬁed CCI, and
vascular risk factors (i.e., hypertension, hyperlipidemia, prior
stroke, and atrial ﬁbrillation) as covariates.24 Comorbidities already
included in the modiﬁed CCI, such as diabetes mellitus, coronary
heart disease, and chronic kidney disease, were excluded to avoid
over-adjustment. Other major covariates, including body mass in-
dex, smoking status, and drinking habits, were not considered
because they are not recorded in the NHIRD. We then added the
NIHSS or the SSI as a continuous variable to the base models. Model
ﬁt was examined using the Hosmer-Lemeshow statistic, and model
discrimination was assessed and compared using the area under
the receiver operating characteristic curve (AUC). The explained
variance (R2) of the model was estimated using the Nagelkerke R2
statistic.27 We further quantiﬁed the improvement in predictive
ability after adding the stroke severity measure to the base model
using integrated discrimination improvement (IDI) and category-
free net reclassiﬁcation improvement (NRI).28,29 The IDI measures
performance of predictive models based on integrated sensitivity
and speciﬁcity and offers incremental information over the con-
ventional AUC.28 The category-free NRI, which does not depend on
pre-deﬁned risk categories, measures reclassiﬁcation of event and
non-event subjects to a higher or lower predicted probability and is
considered an objective measure of improvement in riskprediction.29 Higher IDI and NRI indicate better discrimination and
improved ability to classify a health condition.
3. Results
Overall, 1504 adult patients hospitalized for ICH (1059 from Chi
Mei Medical Center, 248 from Landseed Hospital, and 197 from
Ditmanson Medical Foundation Chiayi Christian Hospital) were
identiﬁed from the stroke registries. After linkage with the NHIRD,
1360 patients (955, 239, and 166 patients from the three hospitals,
respectively) were available for analysis. No patient shared the
same values in all four matching characteristics. Overall, the rate of
successful linkage was 90.4%. Table 2 gives the overall patientInstitutes of Health Stroke Scale; SSI, stroke severity index.
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components differed across the three hospitals (eTable 3). Of the
1360 patients ultimately included in the cohort, follow-up data
were available from 1171 patients (86.1%) at 3 months, 1140 pa-
tients (83.8%) at 6 months, and 758 patients (55.7%) at 1 year after
the index hospitalization. The mortality rates were 16.9% at 3
months, 19.2% at 6 months, and 32.1% at 1 year. The SSI correlated
highly with the admission NIHSS (Pearson correlation coefﬁcient,
r ¼ 0.731; 95% conﬁdence interval [CI], 0.705e0.755). In addition,
the SSI correlated closely with the 3-month mRS (r ¼ 0.696; 95% CI,
0.665e0.724), 6-month mRS (r ¼ 0.685; 95% CI, 0.653e0.715), and
1-year mRS (r ¼ 0.664; 95% CI 0.622e0.702), even though the
correlation decreased as the time from stroke onset increased.
eFig. 1 further demonstrates these correlations for each study
hospital. Fig. 1 displays the box-plots showing distribution of the
SSI and the NIHSS scores across all mRS grades at 3 months, 6
months, and 1 year after ICH. The relationship between SSI and
mRS was not exactly linear for mRS 1 or 5.
eTables 4, 5 and 6 report the logistic regression models for 3-
month, 6-month, and 1-year mortality, respectively. In the base
model for 3-month mortality, hypertension and hyperlipidemia
predicted a lower risk, while a high CCI score (2) predicted a
higher risk of 3-month mortality. When the NIHSS or the SSI was
added to the base model, hypertension remained a signiﬁcant and
independent predictor of 3-month mortality, whereas hyperlipid-
emiawas no longer associatedwithmortality. The effect estimate of
the CCI was equal or close to the null. In the base model for 6-
month mortality, age, CCI score, hypertension, and hyperlipid-
emia were signiﬁcantly associated with mortality. The signiﬁcance
of the CCI score and hyperlipidemia disappeared after the NIHSS or
the SSI was included in the model. In the base model for 1-year
mortality, age, CCI score, hypertension, and hyperlipidemia were
signiﬁcant factors affecting mortality. After including the NIHSS or
the SSI to the base model, the association of hyperlipidemia with
mortality became null, and the effect estimate of the CCI was equal
or close to the null. Stroke severity, measured by either the NIHSS or
the SSI, consistently predicted mortality at all three time points.
Fig. 2 and Table 3 show the performance of these mortality
models. For the base models, which did not contain any measure of
stroke severity, the AUCs for predicting 3-month, 6-month, and 1-
year mortality were 0.670, 0.665, and 0.685, respectively. Adding
the NIHSS to the basemodels not only signiﬁcantly increasedmodel
discrimination (assessed using the AUC, category-free NRI, and theFig. 2. Box-plots showing the distribution of the SSI and the NIHSS across all mRS grades
modiﬁed Rankin Scale; NIHSS, National Institutes of Health Stroke Scale; SSI, stroke severitIDI) but also improved explained variance of the model. The AUCs
for 3-month, 6-month, and 1-year mortality models were 0.899,
0.888, and 0.880, respectively (all P< 0.001 comparedwith the base
models). Similarly, model discrimination and explained variance
were enhanced by including the SSI in the base models. The AUCs
for 3-month, 6-month, and 1-year mortality models were 0.831,
0.821, and 0.829, respectively (all P < 0.001 comparedwith the base
models). Although both the NIHSS and the SSI improved model
performance, the AUCs of the models with the NIHSS were signif-
icantly higher than those of the models with the SSI (all P < 0.001
for mortality outcome at all three time points). Similar results were
also obtained for the comparisons of the IDI, NRI, and explained
variance between the models that included the NIHSS and the ones
that included the SSI.
4. Discussion
We conﬁrmed the concurrent validity and predictive validity of
the SSI through its signiﬁcant and positive correlation with the
NIHSS at admission and with the mRS at 3-month, 6-month, and 1-
year follow-up. Adding the SSI to mortality models based on
administrative data for ICH patients signiﬁcantly improved model
discrimination and explained variance of the model, although to a
smaller degree than when the NIHSS was added instead. Further-
more, models that included the NIHSS or the SSI to adjust for stroke
severity resulted in similar effect estimates for most of the cova-
riates, whereas models without adjustment for stroke severity
produced different effect estimates for hyperlipidemia (eTables 4, 5,
and 6).
Prior studies found that lower levels of low-density lipoprotein
cholesterol predicted hematoma growth and death after ICH.30,31
Consistent with these ﬁndings, our data showed that hyperlipid-
emia predicted lower mortality after ICH. However, the effect of
hyperlipidemia on 3-month, 6-month, and 1-year mortality dis-
appeared when either the NIHSS or the SSI was added in the
mortality models. ICH patients with hyperlipidemia in our study
likely had lower stroke severity than those without (the mean [SD]
NIHSS score was 12.7 [0.8] vs. 17.8 [0.4] for patients with and
without hyperlipidemia; t-test, P < 0.001). Therefore, the effect of
hyperlipidemia on mortality risk diminished after adjustment for
stroke severity.
Although hypertension increases the risk of ICH, a previous
study reported that hypertension did not affect mortality rate afterat 3 months (A), 6 months (B), and 1 year (C) after intracerebral hemorrhage. mRS,
y index.
Table 3
Performance of mortality models for intracerebral hemorrhage.
AUC (95% CI) Hosmer-Lemeshow
statistic
P Nagelkerke R2 IDI (95% CI) Category-free NRI
(95% CI)
Mortality at 3 months
Base model 0.670 (0.628e0.712) 14.13 0.078 0.093 Reference Reference
Model with NIHSS 0.899 (0.878e0.919) 8.42 0.394 0.485 0.30 (0.27e0.33) 1.27 (1.12e1.42)
Model with SSI 0.831 (0.804e0.858) 8.45 0.391 0.325 0.15 (0.13e0.17) 0.92 (0.77e1.08)
Mortality at 6 months
Base model 0.665 (0.624e0.706) 4.05 0.853 0.092 Reference Reference
Model with NIHSS 0.888 (0.866e0.910) 11.80 0.160 0.473 0.30 (0.27e0.33) 1.21 (1.06e1.35)
Model with SSI 0.821 (0.793e0.849) 9.07 0.337 0.317 0.15 (0.13e0.17) 0.92 (0.77e1.07)
Mortality at 1 year
Base model 0.685 (0.645e0.726) 5.75 0.675 0.137 Reference Reference
Model with NIHSS 0.880 (0.855e0.905) 4.56 0.804 0.512 0.31 (0.28e0.35) 1.18 (1.02e1.33)
Model with SSI 0.829 (0.799e0.859) 10.49 0.232 0.388 0.19 (0.16e0.22) 0.96 (0.81e1.11)
AUC, area under the receiver operating characteristic curve; CI, conﬁdence interval.
IDI, integrated discrimination improvement; NIHSS, National Institutes of Health Stroke Scale; NRI, net reclassiﬁcation improvement; SSI, stroke severity index.
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with greater survival among patients with ICH in our study, in
contrast to the well-known association of hypertension with poor
outcomes in the general population. Similar ﬁndings have been
observed in patients with ischemic stroke and heart failure.33,34
Whether or not these ﬁndings are due to the reverse epidemi-
ology effect deserves further investigation.
Clinical stroke scales, such as the NIHSS, are important tools for
monitoring stroke severity and performing clinical stroke research.
They have been used for predicting stroke outcomes, including
mortality, functional outcome, and hospital readmission in patients
with ICH.3,4,35 The SSI is not meant to replace the existing clinical
stroke scales, but rather to provide a valid proxy to measure stroke
severity and/or to adjust for risk of outcomes in future claims-based
ICH studies, where the details of stroke severity and clinical scales
are often unavailable.13 Although International Classiﬁcation of
Diseases Tenth Revision Clinical Modiﬁcation codes for the NIHSS
were approved in 2014 and will become active in the fall of 2016, it
will still take several years for administrative data sets to include
NIHSS data and to be used to adjust for stroke severity in reporting
hospital mortality and readmission rates.36 Therefore, further
research has been advocated to ascertain stroke severity using
administrative billing codes or electronic health records.14 The SSI
was developed in response to this advocacy and might be useful in
achieving this aim.
In addition to being a valid adjustment for stroke severity when
performing stroke outcome studies or evaluating hospital perfor-
mance using administrative claims data, the SSI might be applicable
in other aspects of research that awaits further investigation. For
example, in epidemiologic studies exploring ICH risk factors, the SSI
can be used to compare stroke severity between patients with or
without a particular risk factor. A previous study using the NHIRD
has revealed that patients with liver cirrhosis were prone to
developing ICH compared with those without liver cirrhosis.6
Through the use of the SSI, investigators now have the opportu-
nity to explore the impact of liver cirrhosis on the severity of ICH.
Our study has certain limitations. First, because the SSI is based
on the management and treatment provided for stroke patients,
variations in practice patterns between hospitals and areas may
inﬂuence the validity of the SSI. Although patient characteristics
varied across the three study hospitals (eTable 3), the SSI exhibited
high correlations with the NIHSS and themRS in patients from each
hospital (eFig. 1). The consistent performance of the SSI across
hospitals of different types may imply a good generalizability to
other hospitals in Taiwan. Second, unlike the NIHSS, which was
generally assessed at a speciﬁc time point, the SSI was based on the
whole care process during a stroke admission. Therefore, the SSI
should be viewed as a global measure of neurologic deﬁcit severityfor the entire period of an admission. Third, the performance of the
SSI is largely dependent on the accuracy of administrative claims
data. Although health care providers are unlikely to under-report
treatments during a stroke admission because of the fee-for-
service reimbursement system of the NHI, we could not exclude
the opposite; that is, the potential of over-reporting of treatments
for reimbursement purposes.5. Conclusions
We established the criterion-related validity of the claims-based
SSI in patients with ICH. The SSI may be useful as a proxy for stroke
severity and for controlling confounding in outcomes research
based on the NHIRD or similar claims databases. More validation
studies are needed to test the generalizability of the index to other
administrative databases and other healthcare systems.Conﬂicts of interest
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